240 related articles for article (PubMed ID: 6835724)
1. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.
Baron R; Gertner JM; Lang R; Vignery A
Pediatr Res; 1983 Mar; 17(3):204-7. PubMed ID: 6835724
[TBL] [Abstract][Full Text] [Related]
2. Bone cell defects in osteogenesis imperfecta.
Vignery A
Connect Tissue Res; 1995; 31(4):275-8. PubMed ID: 15612367
[TBL] [Abstract][Full Text] [Related]
3. Osteogenesis imperfecta tarda. The morphology of rib biopsies.
Albright JP; Albright JA; Crelin ES
Clin Orthop Relat Res; 1975 May; (108):204-13. PubMed ID: 1139829
[TBL] [Abstract][Full Text] [Related]
4. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F
Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age.
Fedarko NS; D'Avis P; Frazier CR; Burrill MJ; Fergusson V; Tayback M; Sponseller PD; Shapiro JR
J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947
[TBL] [Abstract][Full Text] [Related]
6. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.
Rauch F; Travers R; Plotkin H; Glorieux FH
J Clin Invest; 2002 Nov; 110(9):1293-9. PubMed ID: 12417568
[TBL] [Abstract][Full Text] [Related]
7. [Pathologic anatomy of osteogenesis imperfecta. Light and electron microscopic studies of supportive tissue and skin].
Stöss H
Veroff Pathol; 1990; 134():1-88. PubMed ID: 2385955
[TBL] [Abstract][Full Text] [Related]
8. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
Sarathchandra P; Cassella JP; Ali SY
Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
[TBL] [Abstract][Full Text] [Related]
9. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
10. Iliac bone histomorphometry in adults and children with osteogenesis imperfecta.
Ste-Marie LG; Charhon SA; Edouard C; Chapuy MC; Meunier PJ
J Clin Pathol; 1984 Oct; 37(10):1081-9. PubMed ID: 6490947
[TBL] [Abstract][Full Text] [Related]
11. Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study.
Edouard T; Glorieux FH; Rauch F
J Bone Miner Res; 2011 Sep; 26(9):2245-51. PubMed ID: 21544864
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.
Shapiro JR; McCarthy EF; Rossiter K; Ernest K; Gelman R; Fedarko N; Santiago HT; Bober M
Calcif Tissue Int; 2003 Feb; 72(2):103-12. PubMed ID: 12457260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nanoindentation measurements between osteogenesis imperfecta Type III and Type IV and between different anatomic locations (femur/tibia versus iliac crest).
Fan Z; Smith PA; Harris GF; Rauch F; Bajorunaite R
Connect Tissue Res; 2007; 48(2):70-5. PubMed ID: 17453908
[TBL] [Abstract][Full Text] [Related]
14. Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone.
Rauch F; Travers R; Norman ME; Taylor A; Parfitt AM; Glorieux FH
J Bone Miner Res; 2000 May; 15(5):957-63. PubMed ID: 10804027
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.
Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K
Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299
[TBL] [Abstract][Full Text] [Related]
16. Increased bone resorption with decreased activity and increased recruitment of osteoblasts in osteogenesis imperfecta type I.
Iwamoto J; Takeda T; Ichimura S
J Bone Miner Metab; 2002; 20(3):174-9. PubMed ID: 11984701
[TBL] [Abstract][Full Text] [Related]
17. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
Rauch F; Lalic L; Roughley P; Glorieux FH
J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
[TBL] [Abstract][Full Text] [Related]
18. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.
Fedarko NS; Sponseller PD; Shapiro JR
J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177
[TBL] [Abstract][Full Text] [Related]
19. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
[TBL] [Abstract][Full Text] [Related]
20. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
Rauch F; Munns CF; Land C; Cheung M; Glorieux FH
J Bone Miner Res; 2009 Jul; 24(7):1282-9. PubMed ID: 19257821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
